This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

AI-aided musical works to be rejected by South Korea copyright collective

By Choonsik Yoo ( April 1, 2025, 07:03 GMT | Insight) -- Amid growing copyright issues involving AI, the Korea Music Copyright Association said it will only approve the registration of musical works when applicants give assurances that they did not use AI and that the work was made solely by human creative contributions. The move by South Korea's largest copyright collective for musical works comes as a tentative measure to address the growing use of AI in the creation of musical works, while the country has yet to revise the Copyright Act and related rules on how the copyright system should treat the use of AI. In a significant move by the private sector to better address copyright issues arising from the widespread use of artificial intelligence in the creation of artworks, a major South Korean copyright collective has decided to not allow the registration of musical works created using AI technology....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login